WeightLossComparison WeightLossComparison
Treatment overview

Saxenda

Compare the practical questions around this treatment, including suitability, access route, support and when provider information should be checked directly.

Last reviewed: 2026-04-25Reviewer: Editorial team
Quick answer

Saxenda is a daily liraglutide injection and is mainly useful as a legacy injection comparison

What it is: Saxenda is the brand name for liraglutide, a daily prescription injection route that may be compared against newer weekly injection options.

Best next step: Use this page to understand where Saxenda fits, then compare current weekly injection options if Saxenda is not the route you are checking.

01

Best for

People researching older or legacy injection options and how they differ from weekly injections.

02

Compare against

Mounjaro and Wegovy for current weekly injection comparison.

03

Do not skip

Suitability, side effects, contraindications and support must be assessed by a regulated healthcare professional where required.

Decision table

Where Saxenda fits

Question Answer Why it matters
Format Daily prescription injection. Different from weekly injection routes.
Main comparison Saxenda vs weekly injection options. Frequency and current availability questions matter.
Provider choice Check whether current provider information is still available and relevant. Availability can change over time.
Best next page Use the injections hub or Mounjaro vs Wegovy page. Many visitors will need current weekly-injection context.
Best for

Who may find this page useful?

Legacy injection context

Best when you want to understand where Saxenda fits historically and practically.

Daily vs weekly question

Best when injection frequency is part of the comparison.

Alternative research

Best as a stepping stone to Mounjaro or Wegovy comparisons.

Clinician discussion

Best used to frame questions for a regulated healthcare professional.

Pros to compare

  • Clear daily injection route to compare against weekly injections.
  • Useful for understanding older injection context.
  • Can help frame questions about alternatives.

Limitations to compare

  • May not be the main current provider-search route.
  • Availability and provider coverage may be limited.
  • Suitability still requires assessment.

NHS vs private

Compare access routes before choosing a provider.

Compare access

Bottom line

Saxenda is best used here as a comparison point against newer weekly injection options, not as the main provider-table destination.


Before you decide: Prices, availability, eligibility and offer details can change. Use this page as a comparison guide, then confirm current information directly with the provider.

Source notes

These notes explain the basis for the page in plain English: what was checked, when it was checked and where the information came from.

Mhra Glp1 Status

MHRA/GOV.UK includes liraglutide among licensed GLP-1 medicines and warns about illegitimate supply channels.

Checked25 April 2026ConfidenceHigh

Source: GLP-1 medicines: what you need to know - GOV.UK / MHRA

Use cautious availability language.

View source